278 related articles for article (PubMed ID: 24525810)
1. Adverse effects from antidepressant treatment: randomised controlled trial of 601 depressed individuals.
Crawford AA; Lewis S; Nutt D; Peters TJ; Cowen P; O'Donovan MC; Wiles N; Lewis G
Psychopharmacology (Berl); 2014 Aug; 231(15):2921-31. PubMed ID: 24525810
[TBL] [Abstract][Full Text] [Related]
2. No effects of antidepressants on negative symptoms in schizophrenia.
Hinkelmann K; Yassouridis A; Kellner M; Jahn H; Wiedemann K; Raedler TJ
J Clin Psychopharmacol; 2013 Oct; 33(5):686-90. PubMed ID: 23857309
[TBL] [Abstract][Full Text] [Related]
3. Sex differences in depressive symptoms and tolerability after treatment with selective serotonin reuptake inhibitor antidepressants: Secondary analyses of the GENPOD trial.
Gougoulaki M; Lewis G; Nutt DJ; Peters TJ; Wiles NJ; Lewis G
J Psychopharmacol; 2021 Aug; 35(8):919-927. PubMed ID: 33637001
[TBL] [Abstract][Full Text] [Related]
4. Severity of depression and response to antidepressants: GENPOD randomised controlled trial.
Wiles NJ; Mulligan J; Peters TJ; Cowen PJ; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Lewis G
Br J Psychiatry; 2012 Feb; 200(2):130-6. PubMed ID: 22194183
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the response to citalopram and reboxetine in post-stroke depressed patients.
Rampello L; Chiechio S; Nicoletti G; Alvano A; Vecchio I; Raffaele R; Malaguarnera M
Psychopharmacology (Berl); 2004 Apr; 173(1-2):73-8. PubMed ID: 14685645
[TBL] [Abstract][Full Text] [Related]
6. The effect of serotonergic and noradrenergic antidepressants on face emotion processing in depressed patients.
Tranter R; Bell D; Gutting P; Harmer C; Healy D; Anderson IM
J Affect Disord; 2009 Nov; 118(1-3):87-93. PubMed ID: 19250683
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness of reboxetine versus fluoxetine in patients with atypical depression: a single-blind, randomized clinical trial.
Taner E; Demir EY; Cosar B
Adv Ther; 2006; 23(6):974-87. PubMed ID: 17276965
[TBL] [Abstract][Full Text] [Related]
8. 5-HT(1A)-receptor over-expressing mice: genotype and sex dependent responses to antidepressants in the forced swim-test.
Günther L; Rothe J; Rex A; Voigt JP; Millan MJ; Fink H; Bert B
Neuropharmacology; 2011 Sep; 61(3):433-41. PubMed ID: 21419787
[TBL] [Abstract][Full Text] [Related]
9. Randomized double-blind comparison of serotonergic (Citalopram) versus noradrenergic (Reboxetine) reuptake inhibitors in outpatients with somatoform, DSM-IV-TR pain disorder.
Aragona M; Bancheri L; Perinelli D; Tarsitani L; Pizzimenti A; Conte A; Inghilleri M
Eur J Pain; 2005 Feb; 9(1):33-8. PubMed ID: 15629872
[TBL] [Abstract][Full Text] [Related]
10. Reboxetine, a new noradrenaline selective antidepressant, is at least as effective as fluoxetine in the treatment of depression.
Andreoli V; Caillard V; Deo RS; Rybakowski JK; Versiani M
J Clin Psychopharmacol; 2002 Aug; 22(4):393-9. PubMed ID: 12172339
[TBL] [Abstract][Full Text] [Related]
11. Polymorphism of the 5-HT transporter and response to antidepressants: randomised controlled trial.
Lewis G; Mulligan J; Wiles N; Cowen P; Craddock N; Ikeda M; Grozeva D; Mason V; Nutt D; Sharp D; Tallon D; Thomas L; O'Donovan MC; Peters TJ
Br J Psychiatry; 2011 Jun; 198(6):464-71. PubMed ID: 21263010
[TBL] [Abstract][Full Text] [Related]
12. Differential prediction of first clinical response to serotonergic and noradrenergic antidepressants using the loudness dependence of auditory evoked potentials in patients with major depressive disorder.
Juckel G; Pogarell O; Augustin H; Mulert C; Müller-Siecheneder F; Frodl T; Mavrogiorgou P; Hegerl U
J Clin Psychiatry; 2007 Aug; 68(8):1206-12. PubMed ID: 17854244
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of reboxetine and citalopram on hand-motor function in patients suffering from major depression.
Hegerl U; Mergl R; Henkel V; Pogarell O; Müller-Siecheneder F; Frodl T; Juckel G
Psychopharmacology (Berl); 2005 Feb; 178(1):58-66. PubMed ID: 15316714
[TBL] [Abstract][Full Text] [Related]
14. Different gender response to serotonergic and noradrenergic antidepressants. A comparative study of the efficacy of citalopram and reboxetine.
Berlanga C; Flores-Ramos M
J Affect Disord; 2006 Oct; 95(1-3):119-23. PubMed ID: 16782204
[TBL] [Abstract][Full Text] [Related]
15. Depersonalization-derealization syndrome induced by reboxetine.
Khazaal Y; Zullino DF
Swiss Med Wkly; 2003 Jul; 133(27-28):398-9. PubMed ID: 12947529
[TBL] [Abstract][Full Text] [Related]
16. Basal prolactin values correlate with response to reboxetine treatment in major depression, but not with response to citalopram.
Moeller O; Hetzel G; Michael N; Rothermundt M; Arolt V; Erfurth A
Neuropsychobiology; 2005; 51(2):67-71. PubMed ID: 15741746
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and tolerability of reboxetine compared with imipramine in a double-blind study in patients suffering from major depressive offsodes.
Berzewski H; Van Moffaert M; Gagiano CA
Eur Neuropsychopharmacol; 1997 Apr; 7 Suppl 1():S37-47; discussion S71-3. PubMed ID: 9169309
[TBL] [Abstract][Full Text] [Related]
18. Does baseline fatigue influence treatment response to reboxetine or citalopram in depression? An open label randomized controlled trial.
Bould H; Wiles N; Potokar J; Cowen P; Nutt DJ; Peters TJ; Lewis G
J Psychopharmacol; 2012 May; 26(5):663-9. PubMed ID: 22223618
[TBL] [Abstract][Full Text] [Related]
19. [Reboxetine (Edronax)].
Souery D; Sternon J
Rev Med Brux; 1999 Dec; 20(6):511-6. PubMed ID: 10672775
[TBL] [Abstract][Full Text] [Related]
20. A review of the adverse effects and safety of noradrenergic antidepressants.
Whiskey E; Taylor D
J Psychopharmacol; 2013 Aug; 27(8):732-9. PubMed ID: 23784737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
